Childhood leukodystrophies: A clinical perspective

Expert Review of Neurotherapeutics

Volumn 11, Issue 10, 2011, Pages 1485-1496

  Kohlschütter, Alfried ^a   Eichler, Florian ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

brain white matter; children; degenerative brain disease; metabolic genetic disease; MRI

Indexed keywords

CORTICOTROPIN; FLUDROCORTISONE; GABAPENTIN; GLUCOCORTICOID; LORENZO OIL; SPASMOLYTIC AGENT; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADRENOLEUKODYSTROPHY; AICARDI GOUTIERES SYNDROME; ALEXANDER DISEASE; CADASIL; CANAVAN DISEASE; CEREBELLUM ATROPHY; CEREBROTENDINOUS XANTHOMATOSIS; CHILD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONGENITAL CATARACT; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 2D; CYST; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSPHAGIA; ELECTROPHYSIOLOGY; ENZYME REPLACEMENT; EVOKED AUDITORY RESPONSE; EYE EXAMINATION; FEEDING DISORDER; FUCOSIDOSIS; GENE MUTATION; GLOBOID CELL LEUKODYSTROPHY; HUMAN; HYPODONTIA; HYPOGONADOTROPIC HYPOGONADISM; INFANT; INTESTINAL BLEEDING; LABORATORY TEST; LEUKODYSTROPHY; METACHROMATIC LEUKODYSTROPHY; MULTIPLE SULFATASE DEFICIENCY; NERVE CELL DEGENERATION; NERVE CONDUCTION; NEUROAXONAL DYSTROPHY; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELIZAEUS MERZBACHER DISEASE; PRESCHOOL CHILD; REVIEW; SCHOOL CHILD; SIALIC ACID STORAGE DISEASE; TRICHOTHIODYSTROPHY;

CHILD; HUMANS; INFANT; INFANT, NEWBORN; LEUKODYSTROPHY, GLOBOID CELL; LEUKODYSTROPHY, METACHROMATIC; MAGNETIC RESONANCE IMAGING; NERVE FIBERS, MYELINATED; NEURODEGENERATIVE DISEASES;

EID: 80053486228     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.135     Document Type: Review

References (79)

1. Schiffmann R, van der Knaap MS. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 72(8), 750-759 (2009). to the diagnosis of a leukoencephalopathy
2. Steenweg ME, Vanderver A, Blaser S et al. Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain 133(10), 2971-2982 (2010)
3. Lin J, Faria EC, Da Rocha AJ et al. Leukoencephalopathy with brainstem and spinal cord involvement and normal lactate: a new mutation in the DARS2 gene. J. Child Neurol. 25(11), 1425-1428 (2010)
4. Jose RA, Tulio BF, Carlos MMA Jr et al. Lactate detection by MRS in mitochondrial encephalopathy: optimization of technical parameters. J. Neuroimaging 18(1), 1-8 (2008)
5. Loes DJ, Fatemi A, Melhem ER et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 61(3), 369-374 (2003) (Pubitemid 36975968)
6. Beam D, Poe MD, Provenzale JM et al. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol. Blood Marrow Transplant. 13(6), 665-674 (2007) (Pubitemid 46767994)
7. Provenzale JM, Peddi S, Kurtzberg J, Poe MD, Mukundan S, Escolar M. Correlation of neurodevelopmental features and MRI findings in infantile Krabbes disease. AJR Am. J. Roentgenol. 192(1), 59-65 (2009)
8. Eichler F, Grodd W, Grant E et al. Metachromatic leukodystrophy: a scoring system for brain MR imaging observations. AJNR Am. J. Neuroradiol. 30(10), 1893-1897 (2009)
9. Van der Knaap MS, Valk J. Magnetic Resonance of Myelination and Myelin Disorders. Birkhäuser (Ed.). Springer, Berlin. Germany (2005). pages) for studying MRIs in white matter disorders
10. Husain AM, Altuwaijri M, Aldosari M. Krabbe disease: neurophysiologic studies and MRI correlations. Neurology 63(4), 617-620 (2004) (Pubitemid 39100814)
11. Siddiqi ZA, Sanders DB, Massey JM. Peripheral neuropathy in Krabbe disease: electrodiagnostic findings. Neurology 67(2), 263-267 (2006) (Pubitemid 44305410)
12. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC et al. Brain MRI and electrophysiologic abnormalities in preclinical and clinical adrenomyeloneuropathy. Neurology 42(1), 85-91 (1992)
13. Moser HW, Raymond GV, Dubey P. Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA 294(24), 3131-3134 (2005) (Pubitemid 43016805)
14. Dubey P, Raymond GV, Moser AB, Kharkar S, Bezman L, Moser HW. Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. J. Pediatr. 146(4), 528-532 (2005) (Pubitemid 40469718)
15. Laureti S, Casucci G, Santeusanio F, Angeletti G, Aubourg P, Brunetti P. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addisons disease in young adult male patients. J. Clin. Endocrinol. Metab. 81(2), 470-474 (1996) (Pubitemid 26057571)
16. van der Knaap MS, Pronk JC, Scheper GC. Vanishing white matter disease. Lancet Neurol. 5(5), 413-423 (2006)
17. van der Knaap MS, van Berkel CG, Herms J et al. eIF2B-related disorders: antenatal onset and involvement of multiple organs. Am. J. Hum. Genet. 73(6), 1199-1207 (2003) (Pubitemid 37414232)
18. Garavelli L, Rosato S, Mele A et al. Massive hemobilia and papillomatosis of the gallbladder in metachromatic leukodystrophy: a life-threatening condition. Neuropediatrics 40(6), 284-286 (2009)
19. Mahmood A, Berry J, Wenger DA et al. Metachromatic leukodystrophy: a case of triplets with the late infantile variant and a systematic review of the literature. J. Child Neurol. 25(5), 572-580 (2009)
20. Klick JC, Hauer J. Pediatric palliative care. Curr. Probl. Pediatr. Adolesc. Health Care 40(6), 120-151 (2010)
21. Hauer JM, Wical BS, Charnas L. Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment. Pediatrics 119(2), e519-e522 (2007) (Pubitemid 46397765)
22. Matzner U, Lullmann-Rauch R, Stroobants S et al. Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy. Mol. Ther. 17(4), 600-606 (2009)
23. Kondo Y, Wenger DA, Gallo V, Duncan ID. Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice. Proc. Natl Acad. Sci. USA 102(51), 18670-18675 (2005) (Pubitemid 43011284)
24. Moser HW, Raymond GV, Lu SE et al. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzos oil. Arch. Neurol. 62(7), 1073-1080 (2005) (Pubitemid 41043727)
25. Aubourg P, Blanche S, Jambaque I et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N. Engl. J. Med. 322(26), 1860-1866 (1990) (Pubitemid 20200413)
26. Peters C, Charnas LR, Tan Y et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104(3), 881-888 (2004) (Pubitemid 38970588)
27. Escolar ML, Poe MD, Provenzale JM et al. Transplantation of umbilical-cord blood in babies with infantile Krabbes disease. N. Engl. J. Med. 352(20), 2069-2081 (2005) (Pubitemid 40664308)
28. Biffi A, Lucchini G, Rovelli A, Sessa M. Metachromatic leukodystrophy: an overview of current and prospective treatments. Bone Marrow Transplant. 42(Suppl. 2), S2-S6 (2008)
29. Orchard PJ, Tolar J. Transplant outcomes in leukodystrophies. Semin. Hematol. 47(1), 70-78 (2010)
30. Benhamida S, Pflumio F, Dubart-Kupperschmitt A et al. Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice. Mol. Ther. 7(3), 317-324 (2003) (Pubitemid 36503855)
31. Glazier AM, Nadeau JH, Aitman TJ. Finding genes that underlie complex traits. Science 298(5602), 2345-2349 (2002) (Pubitemid 36014199)
32. Thibert R, Hyland K, Chiles J, Steinberg S, Eichler F. Levodopa response reveals sepiapterin reductase deficiency in a female heterozygote with adrenoleukodystrophy. J. Inherit. Metab. Dis. (2011) (In press)
33. Hauer J. Identifying and managing sources of pain and distress in children with neurological impairment. Pediatr. Ann. 39(4), 198-205 (2010)
34. Malcolm C, Forbat L, Anderson G, Gibson F, Hain R. Challenging symptom profiles of life-limiting conditions in children: a survey of care professionals and families. Palliat. Med. 25(4), 357-364 (2011)
35. Kaiser J. Human genetics. Affordable exomes fill gaps in a catalog of rare diseases. Science 330(6006), 903 (2010)
36. Metzker ML. Sequencing technologies - the next generation. Nat. Rev. Genet. 11(1), 31-46 (2010)
37. Nikles J, Mitchell GK, Schluter P et al. Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative care. J. Clin. Epidemiol. 64(5), 471-480 (2011)
38. Davison JE, Davies NP, English MW et al. Magnetic resonance spectroscopy in the diagnostic evaluation of brainstem lesions in Alexander disease. J. Child Neurol. 26(3), 356-360 (2011)
39. Orcesi S, Pessagno A, Biancheri R et al. Aicardi-Goutires syndrome presenting atypically as a sub-acute leukoencephalopathy. Eur. J. Paediatr. Neurol. 12(5), 408-411 (2008)
40. Orcesi S, La Piana R, Fazzi E. Aicardi- Goutires syndrome. Br. Med. Bull. 89, 183-201 (2009)
41. Zano S, Malik R, Szucs S, Matalon R, Viola RE. Modification of aspartoacylase for potential use in enzyme replacement therapy for the treatment of Canavan disease. Mol. Genet. Metab. 102(2), 176-180 (2011)
42. Hartley J, Westmacott R, Decker J, Shroff M, Yoon G. Childhood-onset CADASIL: clinical, imaging, and neurocognitive features. J. Child Neurol. 25(5), 623-627 (2010)
43. Bjorkhem I, Hansson M. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochem. Biophys. Res. Commun. 396(1), 46-49 (2010)
44. Lancaster JL, Cody JD, Andrews T, Hardies LJ, Hale DE, Fox PT. Myelination in children with partial deletions of chromosome 18q. AJNR Am. J. Neuroradiol. 26(3), 447-454 (2005) (Pubitemid 43085940)
45. Jaeken J, Matthijs G. Congenital disorders of glycosylation: a rapidly expanding disease family. Annu. Rev. Genomics Hum. Genet. 8, 261-278 (2007)
46. Henneke M, Diekmann S, Ohlenbusch A et al. RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection. Nat. Genet. 41(7), 773-775 (2009)
47. Steinfeld R, Grapp M, Kraetzner R et al. Folate receptor a defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am. J. Hum. Genet. 85(3), 354-363 (2009)
48. Mamourian AC, Hopkin JR, Chawla S, Poptani H. Characteristic MR spectroscopy in fucosidosis: in vitro investigation. Pediatr. Radiol. 40(8), 1446-1449 (2010)
49. Tazir M, Nouioua S, Magy L et al. Phenotypic variability in giant axonal neuropathy. Neuromuscul. Disord. 19(4), 270-274 (2009)
50. Srinivasan J, Coleman L, Kornberg AJ. Juvenile onset globoid cell leukodystrophy masquerading as XL-adrenoleukodystrophy. J. Paediatr. Child Health 44(7-8), 459-461 (2008) (Pubitemid 352000287)
51. Del Toro M, Arranz JA, Macaya A et al. Progressive vacuolating glycine leukoencephalopathy with pulmonary hypertension. Ann. Neurol. 60(1), 148-152 (2006)
52. van der Knaap MS, Linnankivi T, Paetau A et al. Hypomyelination with atrophy of the basal ganglia and cerebellum: follow-up and pathology. Neurology 69(2), 166-171 (2007) (Pubitemid 47051721)
53. Rossi A, Biancheri R, Zara F et al. Hypomyelination and congenital cataract: neuroimaging features of a novel inherited white matter disorder. Am. J. Neuroradiol. 29(2), 301-305 (2008) (Pubitemid 351287886)
54. Orcesi S, Tonduti D, Uggetti C, Larizza D, Fazzi E, Balottin U. New case of 4H syndrome and a review of the literature. Pediatr. Neurol. 42(5), 359-364 (2010)
55. Vaurs-Barriere C, Deville M, Sarret C et al. Pelizaeus-Merzbacher-like disease presentation of MCT8 mutated male subjects. Ann. Neurol. 65(1), 114-118 (2009)
56. Bernard G, Thiffault I, Tetreault M et al. Tremor-ataxia with central hypomyelination (TACH) leukodystrophy maps to chromosome 10q22.3-10q23.31. Neurogenetics 11(4), 457-464 (2010)
57. Carrilho I, Santos M, Guimaraes A et al. Infantile neuroaxonal dystrophy: whats most important for the diagnosis? Eur. J. Paediatr. Neurol. 12(6), 491-500 (2008)
58. Briggs TA, Abdel-Salam GM, Balicki M et al. Cerebroretinal microangiopathy with calcifications and cysts (CRMCC). Am. J. Med. Genet. 146A(2), 182-190 (2008)
59. Ferreira M, Torraco A, Rizza T et al. Progressive cavitating leukoencephalopathy associated with respiratory chain complex I deficiency and a novel mutation in NDUFS1. Neurogenetics 12(1), 9-17 (2011)
60. Neubauer BA, Stefanova I, Hubner CA et al. A new type of leukoencephalopathy with metaphyseal chondrodysplasia maps to Xq25-q27. Neurology 67(4), 587-591 (2006) (Pubitemid 44273603)
61. van der Knaap MS, Lai V, Kohler W et al. Megalencephalic leukoencephalopathy with cysts without MLC1 defect. Ann. Neurol. 67(6), 834-837 (2010)
62. Naidu S, Bibat G, Lin D et al. Progressive cavitating leukoencephalopathy: a novel childhood disease. Ann. Neurol. 58(6), 929-938 (2005) (Pubitemid 41746883)
63. Lopez-Hernandez T, Ridder MC, Montolio M et al. Mutant glialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism. Am. J. Hum. Genet. 88(4), 422-432 (2011)
64. Lerman-Sagie T, Leshinsky-Silver E, Watemberg N, Luckman Y, Lev D. White matter involvement in mitochondrial diseases. Mol. Genet. Metab. 84(2), 127-136 (2005) (Pubitemid 40164572)
65. Timothy J, Geller T. SURF-1 gene mutation associated with leukoencephalopathy in a 2-year-old. J. Child Neurol. 24, 1206-1301 (2009)
66. Biancheri R, Rossi D, Cassandrini D, Rossi A, Bruno C, Santorelli FM. Cavitating leukoencephalopathy in a child carrying the mitochondrial A8344G mutation. AJNR Am. J. Neuroradiol. 31(9), E78-E79 (2010)
67. Artigalas OA, da Silva LR, Burin M et al. Multiple sulfatase deficiency: clinical report and description of two novel mutations in a Brazilian patient. Meta. Brain Dis. 24(3), 493-500 (2009)
68. Steenweg ME, Jakobs C, Errami A et al. An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype-phenotype study. Hum Mutat 31(4), 380-390 (2010)
69. Henneke M, Combes P, Diekmann S et al. GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease. Neurology 70(10), 748-754 (2008)
70. Feinstein M, Markus B, Noyman I et al. Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation. Am. J. Hum. Genet. 87(6), 820-828 (2010)
71. Mochel F, Engelke UF, Barritault J et al. Elevated CSF N-acetylaspartylglutamate in patients with free sialic acid storage diseases. Neurology 74(4), 302-305 (2010)
72. Harreld JH, Smith EC, Prose NS, Puri PK, Barboriak DP. Trichothiodystrophy with dysmyelination and central osteosclerosis. Am. J. Neuroradiol. 31(1), 129-130 (2010)
73. van der Lei HDW, van Berkel CGM, van Wieringen WN et al. Genotype- phenotype correlation in vanishing white matter disease. Neurology 75(17), 1555-1559 (2010)
74. Wolf NI, Harting I, Boltshauser E. Leukoencephalopathy with ataxia, hypodontia, and hypomyelination. Neurology 64(8), 1461-1644 (2006)
75. van der Knaap MS, Ramesh V, Schiffmann R et al. Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology 66(4), 494-498 (2006) (Pubitemid 43739875)
76. Krishnamoorthy KS, Eichler FS, Goyal NA, Small JE, Snuderl M. Case records of the Massachusetts General Hospital. Case 3-2010. A 5-month-old boy with developmental delay and irritability. N. Engl. J. Med. 362(4), 346-356 (2010)
77. Dastych M, Gottwaldova J, Pohludka M, Prikryl P, Benovska M. Determination of asialotransferrin in the cerebrospinal fluid with the HPLC method. Scand. J. Clin. Lab. Invest. 70(2), 87-91 (2010)
78. Callahan JW, Skomorowski MA. Diagnosis of Krabbe disease by use of a natural substrate. Methods Mol. Biol. 347, 321-330 (2006)
79. Gorg M, Wilck W, Granitzny B et al. Stabilization of juvenile metachromatic leukodystrophy after bone marrow transplantation: a 13-year follow-up. J. Child Neurol. 22(9), 1139-1142 (2007) (Pubitemid 47412692)